These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 17161036)
1. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Sodee DB; Sodee AE; Bakale G Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036 [TBL] [Abstract][Full Text] [Related]
2. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362 [TBL] [Abstract][Full Text] [Related]
3. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure. Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445 [TBL] [Abstract][Full Text] [Related]
4. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635 [TBL] [Abstract][Full Text] [Related]
5. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Ingui CJ; Shah NP; Oates ME Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381 [TBL] [Abstract][Full Text] [Related]
6. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Horger M; Bares R Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146 [TBL] [Abstract][Full Text] [Related]
7. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma. Schillaci O Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145 [TBL] [Abstract][Full Text] [Related]
8. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer. Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC Clin Imaging; 2009; 33(1):49-54. PubMed ID: 19135930 [TBL] [Abstract][Full Text] [Related]
9. Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors. Wong KK; Cahill JM; Frey KA; Avram AM Acad Radiol; 2010 Mar; 17(3):291-7. PubMed ID: 19962915 [TBL] [Abstract][Full Text] [Related]
10. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer. Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354 [TBL] [Abstract][Full Text] [Related]
11. Computer-aided evaluation of anatomical accuracy of image fusion between X-ray CT and SPECT. Han J; Köstler H; Bennewitz C; Kuwert T; Hornegger J Comput Med Imaging Graph; 2008 Jul; 32(5):388-95. PubMed ID: 18468862 [TBL] [Abstract][Full Text] [Related]
13. Hybrid imaging (SPECT/CT and PET/CT)--improving the diagnostic accuracy of functional/metabolic and anatomic imaging. Even-Sapir E; Keidar Z; Bar-Shalom R Semin Nucl Med; 2009 Jul; 39(4):264-75. PubMed ID: 19497403 [TBL] [Abstract][Full Text] [Related]
14. Optimized scintigraphic evaluation of infection and inflammation: role of single-photon emission computed tomography/computed tomography fusion imaging. Bunyaviroch T; Aggarwal A; Oates ME Semin Nucl Med; 2006 Oct; 36(4):295-311. PubMed ID: 16950147 [TBL] [Abstract][Full Text] [Related]
15. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044 [TBL] [Abstract][Full Text] [Related]
17. C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions. Li X; Liu Q; Wang M; Jin X; Liu Q; Yao S; Liu S; Li J Clin Nucl Med; 2008 Oct; 33(10):671-6. PubMed ID: 18806565 [TBL] [Abstract][Full Text] [Related]
18. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT. Ruf J; Steffen I; Mehl S; Rosner C; Denecke T; Pape UF; Plotkin M; Amthauer H Nucl Med Commun; 2007 Oct; 28(10):782-8. PubMed ID: 17728608 [TBL] [Abstract][Full Text] [Related]
19. SPECT/CT imaging using a spiral CT scanner for anatomical localization: Impact on diagnostic accuracy and reporter confidence in clinical practice. Roach PJ; Schembri GP; Ho Shon IA; Bailey EA; Bailey DL Nucl Med Commun; 2006 Dec; 27(12):977-87. PubMed ID: 17088684 [TBL] [Abstract][Full Text] [Related]
20. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. Martorana G; Schiavina R; Corti B; Farsad M; Salizzoni E; Brunocilla E; Bertaccini A; Manferrari F; Castellucci P; Fanti S; Canini R; Grigioni WF; D'Errico Grigioni A J Urol; 2006 Sep; 176(3):954-60; discussion 960. PubMed ID: 16890665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]